Overview

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
0
Participant gender:
Female
Summary
This study aims to investigate the safety and the analgesic efficacy of adding Ketamine to bupivacaine 0.25% in thoracic PVB in patients undergoing modified radical mastectomy.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Treatments:
Analgesics
Bupivacaine
Ketamine
Criteria
Inclusion Criteria:

- all patients scheduled for elective modified radical mastectomy with axillary
dissection will be enrolled in the study

Exclusion Criteria:

- patients with a known allergy to the study drugs

- patients with bleeding diathesis

- patients with infection at the site of injection

- patients with central neuropathy

- patients with liver impairment

- patients with renal impairment

- drugs or alcohol abusers

- patients with psychiatric illnesses